학술논문
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
Document Type
Article
Author
Source
In: Molecular Therapy Nucleic Acids . (Molecular Therapy Nucleic Acids, 2 March 2018, 10:317-330)
Subject
Language
English
ISSN
21622531